Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.42 |
| ▸ | FASN | P49327 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.31 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10043291 | 0.91 | KDM1A (0.41) | KDM1AFASNALDH1A1CCNT1CDK9 | |
| SCHEMBL10043321 | 0.87 | KDM1A (0.53) | KDM1AFASNNAAAESR2ALDH1A1 | |
| SCHEMBL10043107 | 0.87 | KDM1A (0.53) | KDM1AFASNNAAAESR2ALDH1A1 | |
| SCHEMBL15061092 | 0.87 | KDM1A (0.38) | KDM1ANAAACCNT1CDK9 | |
| SCHEMBL22622838 | 0.86 | KDM1A (0.55) | KDM1AFASNNAAAESR2ALDH1A1 | |
| SCHEMBL10072171 | 0.85 | KDM1A (0.37) | KDM1A | |
| SCHEMBL10043142 | 0.85 | KDM1A (0.41) | KDM1AFASNALDH1A1 | |
| SCHEMBL12975808 | 0.84 | FASN (0.35) | FASNESR2 | |
| SCHEMBL10043315 | 0.83 | FASN (0.33) | KDM1AFASNESR2ALDH1A1 | |
| SCHEMBL12716160 | 0.82 | KDM1A (0.58) | KDM1AFASNNAAAESR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8470199-B2 | Five-ring liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20120074355-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120074355-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | HTR3D, KIF23, CCND3 | KDM1A 821/4885FASN 1950/4885NAAA 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.